Latest Content

Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera

August 25th 2025, 8:00pm

By Ryan Scott

Article

The FDA has granted rusfertide breakthrough therapy designation for patients with polycythemia vera, a step that could speed its path to approval.

Biopsy Alone May Miss Risk in Grade Group 1 Prostate Cancer

August 25th 2025, 7:00pm

By Spencer Feldman

Article

Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume should also guide treatment.

HMAs Underutilized in Older, Female and Non-White Patients with MDS

August 25th 2025, 5:00pm

By Alex Biese

Article

In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients.

Find Your Own Metaphors: Advice For Cancer Survivors

August 25th 2025, 4:00pm

By Felicia Mitchell

Article

Creating our own metaphors to stand up to cancer can help with the healing journey; own words can give us a better sense of control.

DecisionDx-SCC Test Helps Predict Outcomes in High-Risk Skin Cancer

August 25th 2025, 3:00pm

By Ryan Scott

Article

DecisionDx-SCC may help doctors more accurately guide treatment in high-risk cutaneous squamous cell carcinoma, the second most common form of skin cancer.

Hope and Support Guides Survivor Through Ovarian Cancer Journey

August 25th 2025, 1:00pm

By Spencer Feldman

Article

A survivor shares how family, care teams and mentoring others helped her face stage 3C ovarian cancer and reclaim independence with hope.

Vaccine Reduces Recurrence and Death in Pancreatic, Colorectal Cancers

August 24th 2025, 6:00pm

By Dr. Zev Wainberg

Video

An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.

Why Is Specialized Care Important For GIST Treatment?

August 24th 2025, 2:00pm

By Ryan Scott

Article

It is vital to acknowledge early symptoms, seek specialized care, as well as an expert opinion when it comes to gastrointestinal stromal tumor treatment.

FDA Approval of Modeyso For Glioma May Lead to Combination Therapies

August 23rd 2025, 6:00pm

By Alex Biese

Article

The FDA’s accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation sets the stage for more treatment advancements.

Helping Patients Reconnect With Food After Cancer Treatment

August 23rd 2025, 2:00pm

By Spencer Feldman

Article

Dena Champion, dietician, explains how taste/smell changes from cancer treatment can make eating difficult and affect recovery.

Breast Cancer: What You Need to Know About Types, Staging and Genetics

August 22nd 2025, 9:00pm

By Spencer Feldman

Article

Breast cancer types, staging, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make informed care decisions.

Navigating Your Early-Stage Kidney Cancer Diagnosis

August 22nd 2025, 8:00pm

By Ryan Scott

Article

Early-stage kidney cancer is limited to the kidney, usually under seven centimeters and often has a very good prognosis when treated promptly.

Understanding Bladder Cancer: Types, Diagnosis and Treatment Options

August 22nd 2025, 7:00pm

By Alex Biese

Article

This guide provides an overview of bladder cancer, from diagnosis to treatment, helping patients understand options, manage side effects, and plan care.

Blogging is a Great Way to Chronicle a Breast Cancer Journey

August 22nd 2025, 5:00pm

By Bonnie Annis

Article

After my breast cancer diagnosis, blogging became a way to process emotions, share updates with loved ones, and connect with others facing similar journeys

Various Clinical Trials in Oncology Announce Key Trial Milestones

August 22nd 2025, 4:03pm

By Ryan Scott

Article

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid tumors.